<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet href="https://rss.buzzsprout.com/styles.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:psc="http://podlove.org/simple-chapters" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <atom:link href="https://feeds.buzzsprout.com/1062154.rss" rel="self" type="application/rss+xml" />
  <atom:link href="https://pubsubhubbub.appspot.com/" rel="hub" xmlns="http://www.w3.org/2005/Atom" />
  <title>The Lancet HIV in conversation with</title>

  <lastBuildDate>Wed, 04 Mar 2026 18:19:23 -0500</lastBuildDate>
  <link>https://www.thelancet.com/journals/lanhiv/home</link>
  <language>en-gb</language>
  <copyright>© 2026 The Lancet Group</copyright>
  <podcast:locked>yes</podcast:locked>
    <podcast:guid>3fe4d2d6-bbc2-5565-89d6-5a5779149114</podcast:guid>
  <podcast:txt purpose="verify">podcasts@lancet.com</podcast:txt>
  <itunes:author>The Lancet Group</itunes:author>
  <itunes:type>episodic</itunes:type>
  <itunes:explicit>false</itunes:explicit>
  <description><![CDATA[<p>Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at <em>The Lancet HIV</em>, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.<br><br></p><p>A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.</p>]]></description>
  <generator>Buzzsprout (https://www.buzzsprout.com)</generator>
  <itunes:keywords>PrEP, AIDS, sexual health</itunes:keywords>
  <itunes:owner>
    <itunes:name>The Lancet Group</itunes:name>
    <itunes:email>podcasts@lancet.com</itunes:email>
  </itunes:owner>
  <image>
     <url>https://storage.buzzsprout.com/e3eyrbslr26ng72w67oflkzz43e1?.jpg</url>
     <title>The Lancet HIV in conversation with</title>
     <link>https://www.thelancet.com/journals/lanhiv/home</link>
  </image>
  <itunes:image href="https://storage.buzzsprout.com/e3eyrbslr26ng72w67oflkzz43e1?.jpg" />
  <itunes:category text="Health &amp; Fitness">
    <itunes:category text="Medicine" />
  </itunes:category>
  <itunes:category text="Science">
    <itunes:category text="Life Sciences" />
  </itunes:category>
  <itunes:category text="Education" />
  <item>
    <itunes:title>Solange Baptiste, Charles Holmes, and Kenneth Ngure on sustainable HIV prevention in Africa</itunes:title>
    <title>Solange Baptiste, Charles Holmes, and Kenneth Ngure on sustainable HIV prevention in Africa</title>
    <itunes:summary><![CDATA[Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on the Series.  Together they discuss withstanding external funding shocks, meaningful community in...]]></itunes:summary>
    <description><![CDATA[<p>Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on the Series.<br/><br/>Together they discuss withstanding external funding shocks, meaningful community involvement, and focusing on health equity, as part of a sustainable approach to HIV prevention in Africa.</p><p>Click here to read the full series: <a href='https://www.thelancet.com/series-do/sustainable-hiv-prevention-africa?dgcid=tlcom_podcast_acq-hivprevention25_lanhiv'><b>https://www.thelancet.com/series-do/sustainable-hiv-prevention-africa<br/></b></a><br/><br/></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on the Series.<br/><br/>Together they discuss withstanding external funding shocks, meaningful community involvement, and focusing on health equity, as part of a sustainable approach to HIV prevention in Africa.</p><p>Click here to read the full series: <a href='https://www.thelancet.com/series-do/sustainable-hiv-prevention-africa?dgcid=tlcom_podcast_acq-hivprevention25_lanhiv'><b>https://www.thelancet.com/series-do/sustainable-hiv-prevention-africa<br/></b></a><br/><br/></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/18323877-solange-baptiste-charles-holmes-and-kenneth-ngure-on-sustainable-hiv-prevention-in-africa.mp3" length="31217470" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18323877</guid>
    <pubDate>Tue, 09 Dec 2025 23:00:00 +0000</pubDate>
    <itunes:duration>2598</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Luxena Sukumaran and Alan Winston on disordered sleep in people living with HIV</itunes:title>
    <title>Luxena Sukumaran and Alan Winston on disordered sleep in people living with HIV</title>
    <itunes:summary><![CDATA[Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips for people living with HIV experiencing sleep disturbances. Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00221-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://...]]></itunes:summary>
    <description><![CDATA[<p>Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips for people living with HIV experiencing sleep disturbances.</p><p>Click here to read the full article: <a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00221-8/fulltext?dgcid=tlcom_podcast_acq-december25_lanhiv'><b>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00221-8/fulltext</b></a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips for people living with HIV experiencing sleep disturbances.</p><p>Click here to read the full article: <a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00221-8/fulltext?dgcid=tlcom_podcast_acq-december25_lanhiv'><b>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00221-8/fulltext</b></a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/18223516-luxena-sukumaran-and-alan-winston-on-disordered-sleep-in-people-living-with-hiv.mp3" length="15199617" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18223516</guid>
    <pubDate>Wed, 26 Nov 2025 23:00:00 +0000</pubDate>
    <itunes:duration>1264</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Deborah Persaud on the possibility of HIV remission in neonates</itunes:title>
    <title>Deborah Persaud on the possibility of HIV remission in neonates</title>
    <itunes:summary><![CDATA[In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to a lead investigator about what we know so far. Read the full article: www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00189-4/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup http...]]></itunes:summary>
    <description><![CDATA[<p>In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to a lead investigator about what we know so far.</p><p>Read the full article: <a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00189-4/fulltext?dgcid=tlcom_podcast_acq-november-2025_lanhiv'><b>www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00189-4/fulltext</b></a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to a lead investigator about what we know so far.</p><p>Read the full article: <a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00189-4/fulltext?dgcid=tlcom_podcast_acq-november-2025_lanhiv'><b>www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00189-4/fulltext</b></a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/18106495-deborah-persaud-on-the-possibility-of-hiv-remission-in-neonates.mp3" length="25703160" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-18106495</guid>
    <pubDate>Tue, 04 Nov 2025 23:00:00 +0000</pubDate>
    <itunes:duration>2139</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis</itunes:title>
    <title>Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis</title>
    <itunes:summary><![CDATA[Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new research showing why targeting cytomegalovirus could be key to improving outcomes for people living with advanced HIV. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00163-8/fulltext?dgcid=buzzsprout_icw_podcast_October_25_lanhiv Cont...]]></itunes:summary>
    <description><![CDATA[<p>Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new research showing why targeting cytomegalovirus could be key to improving outcomes for people living with advanced HIV.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00163-8/fulltext?dgcid=buzzsprout_icw_podcast_October_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00163-8/fulltext?dgcid=buzzsprout_icw_podcast_October_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new research showing why targeting cytomegalovirus could be key to improving outcomes for people living with advanced HIV.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00163-8/fulltext?dgcid=buzzsprout_icw_podcast_October_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00163-8/fulltext?dgcid=buzzsprout_icw_podcast_October_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/17903986-jayne-ellis-on-cytomegalovirus-and-epstein-barr-virus-in-people-with-hiv-associated-cryptococcal-meningitis.mp3" length="12562395" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17903986</guid>
    <pubDate>Wed, 01 Oct 2025 23:00:00 +0100</pubDate>
    <itunes:duration>1045</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV</itunes:title>
    <title>Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV</title>
    <itunes:summary><![CDATA[Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into factors that affect the probability of vertical transmission and what it says about efforts to end new infant acquisitions. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00132-8/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanhiv Cont...]]></itunes:summary>
    <description><![CDATA[<p>Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into factors that affect the probability of vertical transmission and what it says about efforts to end new infant acquisitions.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00132-8/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00132-8/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into factors that affect the probability of vertical transmission and what it says about efforts to end new infant acquisitions.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00132-8/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00132-8/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/17742281-maggie-walters-and-michelle-bulterys-on-the-probability-of-vertical-transmission-of-hiv.mp3" length="13389287" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17742281</guid>
    <pubDate>Thu, 28 Aug 2025 13:00:00 +0100</pubDate>
    <itunes:duration>1113</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda</itunes:title>
    <title>Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda</title>
    <itunes:summary><![CDATA[Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprou...]]></itunes:summary>
    <description><![CDATA[<p>Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/17574940-mansoor-farahani-wafaa-el-sadr-and-wilford-kirungi-on-the-progress-in-the-hiv-response-in-uganda.mp3" length="18222313" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17574940</guid>
    <pubDate>Wed, 30 Jul 2025 23:00:00 +0100</pubDate>
    <itunes:duration>1516</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV</itunes:title>
    <title>Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV</title>
    <itunes:summary><![CDATA[In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h...]]></itunes:summary>
    <description><![CDATA[<p>In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/17409129-richard-wu-on-a-phase-1-trial-of-a-broadly-neutralising-antibody-for-hiv.mp3" length="11825605" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17409129</guid>
    <pubDate>Tue, 01 Jul 2025 12:00:00 +0100</pubDate>
    <itunes:duration>983</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV</itunes:title>
    <title>Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV</title>
    <itunes:summary><![CDATA[Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese University of Hong Kong) as they discuss whether a dietary and exercise programme can reduce liver fat and induce resolution of MASLD in people with HIV. Read the full article: https://www.thelancet.com/journals/lanh...]]></itunes:summary>
    <description><![CDATA[<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese University of Hong Kong) as they discuss whether a dietary and exercise programme can reduce liver fat and induce resolution of MASLD in people with HIV.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00032-3?dgcid=buzzsprout_icw_podcast_May_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00032-3?dgcid=buzzsprout_icw_podcast_May_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese University of Hong Kong) as they discuss whether a dietary and exercise programme can reduce liver fat and induce resolution of MASLD in people with HIV.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00032-3?dgcid=buzzsprout_icw_podcast_May_25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00032-3?dgcid=buzzsprout_icw_podcast_May_25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/17208835-grace-lui-and-vincent-wong-on-lifestyle-modifications-to-address-masld-in-people-with-hiv.mp3" length="9983379" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17208835</guid>
    <pubDate>Tue, 27 May 2025 23:00:00 +0100</pubDate>
    <itunes:duration>830</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality</itunes:title>
    <title>Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality</title>
    <itunes:summary><![CDATA[Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic?  Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss their modelling study forecasting the effects of funding cuts on HIV acquisitions and mortality. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00074-8/fulltext?dgcid=buzzsprout...]]></itunes:summary>
    <description><![CDATA[<p>Could cuts to international aid by the world&apos;s richest nations really undo 30 years of progress in combatting the HIV pandemic? </p><p>Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss their modelling study forecasting the effects of funding cuts on HIV acquisitions and mortality.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00074-8/fulltext?dgcid=buzzsprout_icw_podcast_30-04-25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00074-8/fulltext?dgcid=buzzsprout_icw_podcast_30-04-25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Could cuts to international aid by the world&apos;s richest nations really undo 30 years of progress in combatting the HIV pandemic? </p><p>Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss their modelling study forecasting the effects of funding cuts on HIV acquisitions and mortality.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00074-8/fulltext?dgcid=buzzsprout_icw_podcast_30-04-25_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00074-8/fulltext?dgcid=buzzsprout_icw_podcast_30-04-25_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/17027053-debra-ten-brink-and-rowan-martin-hughes-on-the-effects-of-international-aid-cuts-on-hiv-acquisitions-and-mortality.mp3" length="17312657" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-17027053</guid>
    <pubDate>Wed, 30 Apr 2025 23:00:00 +0100</pubDate>
    <itunes:duration>1440</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes</itunes:title>
    <title>Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes</title>
    <itunes:summary><![CDATA[Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression. Read the article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv And the personal view: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid...]]></itunes:summary>
    <description><![CDATA[<p>Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression.</p><p>Read the article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>And the personal view:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression.</p><p>Read the article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>And the personal view:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/16849993-sari-reisner-on-the-benefits-of-gender-affirming-hormone-therapy-on-hiv-clinical-outcomes.mp3" length="15489155" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16849993</guid>
    <pubDate>Thu, 27 Mar 2025 23:00:00 +0000</pubDate>
    <itunes:duration>1288</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women</itunes:title>
    <title>Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women</title>
    <itunes:summary><![CDATA[Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h...]]></itunes:summary>
    <description><![CDATA[<p>Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women.</p><p>Read the full article:</p><p><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/16771820-lisa-noguchi-and-nyaradzo-mgodi-on-hiv-prophylactic-dapivirine-ring-in-breastfeeding-women.mp3" length="16615074" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16771820</guid>
    <pubDate>Tue, 11 Mar 2025 14:00:00 +0000</pubDate>
    <itunes:duration>1382</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure</itunes:title>
    <title>Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure</title>
    <itunes:summary><![CDATA[Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagr...]]></itunes:summary>
    <description><![CDATA[<p>Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/16518758-sharon-lewin-on-requirements-of-a-cell-and-gene-based-therapy-product-for-hiv-cure.mp3" length="18023740" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16518758</guid>
    <pubDate>Tue, 04 Feb 2025 23:00:00 +0000</pubDate>
    <itunes:duration>1499</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish)</itunes:title>
    <title>Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish)</title>
    <itunes:summary><![CDATA[Please note: this podcast is entirely in Spanish  Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiza) sobre los desafios a los que se enfrentan las poblaciones migrantes en el marco de la prevención y el tratamiento del VIH.  Lea la Serie completa: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00233-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhi...]]></itunes:summary>
    <description><![CDATA[<p><b><em>Please note: this podcast is entirely in Spanish</em></b><b><br/></b><br/>Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiza) sobre los desafios a los que se enfrentan las poblaciones migrantes en el marco de la prevención y el tratamiento del VIH.<br/><br/>Lea la Serie completa:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00233-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00233-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p><b><em>Please note: this podcast is entirely in Spanish</em></b><b><br/></b><br/>Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiza) sobre los desafios a los que se enfrentan las poblaciones migrantes en el marco de la prevención y el tratamiento del VIH.<br/><br/>Lea la Serie completa:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00233-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00233-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/16183968-claudia-cortes-y-giovanni-ravasi-sobre-vih-y-migracion-in-spanish.mp3" length="24138162" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16183968</guid>
    <pubDate>Thu, 05 Dec 2024 14:00:00 +0000</pubDate>
    <itunes:duration>2009</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Florence Riako Anam and Bruce Richman on U=U</itunes:title>
    <title>Florence Riako Anam and Bruce Richman on U=U</title>
    <itunes:summary><![CDATA[Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat.  Read the full Article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00241-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv  Read related content here: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018...]]></itunes:summary>
    <description><![CDATA[<p>Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat.<br/><br/>Read the full Article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00241-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00241-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a><br/><br/>Read related content here:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30132-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30132-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30226-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30226-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat.<br/><br/>Read the full Article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00241-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00241-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a><br/><br/>Read related content here:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30132-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30132-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30226-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30226-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/16084863-florence-riako-anam-and-bruce-richman-on-u-u.mp3" length="18672543" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-16084863</guid>
    <pubDate>Thu, 14 Nov 2024 11:00:00 +0000</pubDate>
    <itunes:duration>1553</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Peter Hayward on 10 years of The Lancet HIV</itunes:title>
    <title>Peter Hayward on 10 years of The Lancet HIV</title>
    <itunes:summary><![CDATA[Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of The Lancet HIV.  Read this month´s anniversary editorial here: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00245-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/t...]]></itunes:summary>
    <description><![CDATA[<p>Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of <em>The Lancet HIV.<br/><br/></em>Read this month´s anniversary editorial here:<em> </em><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00245-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00245-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of <em>The Lancet HIV.<br/><br/></em>Read this month´s anniversary editorial here:<em> </em><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00245-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00245-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/15827203-peter-hayward-on-10-years-of-the-lancet-hiv.mp3" length="16858494" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15827203</guid>
    <pubDate>Mon, 30 Sep 2024 23:00:00 +0100</pubDate>
    <itunes:duration>1402</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa</itunes:title>
    <title>Salome Kuchukidze and Souleymane Diabaté on the link between intimate partner violence and vertical HIV transmission in sub-Saharan Africa</title>
    <itunes:summary><![CDATA[Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00148-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https:/...]]></itunes:summary>
    <description><![CDATA[<p>Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00148-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00148-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00148-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00148-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/15440158-salome-kuchukidze-and-souleymane-diabate-on-the-link-between-intimate-partner-violence-and-vertical-hiv-transmission-in-sub-saharan-africa.mp3" length="17537345" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15440158</guid>
    <pubDate>Tue, 23 Jul 2024 10:00:00 +0100</pubDate>
    <itunes:duration>1459</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>José M. Zuniga on the future of urban HIV responses Commission</itunes:title>
    <title>José M. Zuniga on the future of urban HIV responses Commission</title>
    <itunes:summary><![CDATA[Adrian Gonzalez is joined by Jose M. Zuniga (IAPAC, Fast-Track Cities Institute) to talk about the IAPAC – Lancet HIV Commission on the future of urban HIV responses. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Adrian Gonzalez is joined by Jose M. Zuniga (IAPAC, Fast-Track Cities Institute) to talk about the IAPAC – Lancet HIV Commission on the future of urban HIV responses.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Adrian Gonzalez is joined by Jose M. Zuniga (IAPAC, Fast-Track Cities Institute) to talk about the IAPAC – Lancet HIV Commission on the future of urban HIV responses.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/15429472-jose-m-zuniga-on-the-future-of-urban-hiv-responses-commission.mp3" length="16433154" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15429472</guid>
    <pubDate>Sat, 20 Jul 2024 23:00:00 +0100</pubDate>
    <itunes:duration>1367</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES)</itunes:title>
    <title>Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH en España (ES)</title>
    <itunes:summary><![CDATA[Adrian Gonzalez (Editor) entrevista Alejandro García García (Departamento de Enfermedades Infecciosas del Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de investigación Sanitaria en Madrid,España) sobre los avances en los tiempos de transición de las personas con VIH en España entre las distintas etapas de su vinculación a la atención médica, desde su diagnóstico hasta alcanzar la supresión viral.  https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00118-8/full...]]></itunes:summary>
    <description><![CDATA[<p>Adrian Gonzalez (Editor) entrevista Alejandro García García (Departamento de Enfermedades Infecciosas del Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de investigación Sanitaria en Madrid,España) sobre los avances en los tiempos de transición de las personas con VIH en España entre las distintas etapas de su vinculación a la atención médica, desde su diagnóstico hasta alcanzar la supresión viral.<br/><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00118-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00118-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Adrian Gonzalez (Editor) entrevista Alejandro García García (Departamento de Enfermedades Infecciosas del Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de investigación Sanitaria en Madrid,España) sobre los avances en los tiempos de transición de las personas con VIH en España entre las distintas etapas de su vinculación a la atención médica, desde su diagnóstico hasta alcanzar la supresión viral.<br/><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00118-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00118-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/15321759-alejandro-garcia-sobre-los-tiempos-de-transicion-en-la-atencion-medica-continuada-del-vih-en-espana-es.mp3" length="18525333" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15321759</guid>
    <pubDate>Mon, 01 Jul 2024 13:00:00 +0100</pubDate>
    <itunes:duration>1541</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Serge Eholie on treatments for HIV-2</itunes:title>
    <title>Serge Eholie on treatments for HIV-2</title>
    <itunes:summary><![CDATA[Professor Serge Eholie (PACCI Programme, Abidjan, Côte d’Ivoire) joins Peter Hayward to discuss a recent randomised trial of treatments for HIV-2 in Burkina Faso, Côte d’Ivoire, Senegal, and Togo.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00085-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com...]]></itunes:summary>
    <description><![CDATA[<p>Professor Serge Eholie (PACCI Programme, Abidjan, Côte d’Ivoire) joins Peter Hayward to discuss a recent randomised trial of treatments for HIV-2 in Burkina Faso, Côte d’Ivoire, Senegal, and Togo.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00085-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00085-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Professor Serge Eholie (PACCI Programme, Abidjan, Côte d’Ivoire) joins Peter Hayward to discuss a recent randomised trial of treatments for HIV-2 in Burkina Faso, Côte d’Ivoire, Senegal, and Togo.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00085-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00085-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/15183829-serge-eholie-on-treatments-for-hiv-2.mp3" length="19299153" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-15183829</guid>
    <pubDate>Wed, 05 Jun 2024 23:00:00 +0100</pubDate>
    <itunes:duration>1605</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana</itunes:title>
    <title>Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana</title>
    <itunes:summary><![CDATA[Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana) on Botswana´s accomplishments and progress towards achieving the UNAIDS 95 targets.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00003-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Fol...]]></itunes:summary>
    <description><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana) on Botswana´s accomplishments and progress towards achieving the UNAIDS 95 targets.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00003-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00003-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana) on Botswana´s accomplishments and progress towards achieving the UNAIDS 95 targets.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00003-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00003-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/14855423-drew-voetsch-and-robert-selato-on-achieving-the-95-95-95-unaids-goals-in-botswana.mp3" length="16024741" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14855423</guid>
    <pubDate>Tue, 09 Apr 2024 11:00:00 +0100</pubDate>
    <itunes:duration>1333</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Adam Trickey on trends in causes of death among people with HIV in Europe and North America</itunes:title>
    <title>Adam Trickey on trends in causes of death among people with HIV in Europe and North America</title>
    <itunes:summary><![CDATA[Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00272-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.co...]]></itunes:summary>
    <description><![CDATA[<p>Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00272-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00272-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00272-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00272-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/14584874-adam-trickey-on-trends-in-causes-of-death-among-people-with-hiv-in-europe-and-north-america.mp3" length="8651021" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14584874</guid>
    <pubDate>Tue, 27 Feb 2024 11:00:00 +0000</pubDate>
    <itunes:duration>718</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK</itunes:title>
    <title>Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK</title>
    <itunes:summary><![CDATA[Deputy Editor Adrian Gonzalez interviews Manik Kohli (Institute of Global Health at the University College London, UK), Iain Reeves (Homerton Healthcare NHS Trust, UK), and Laura Waters (Central and North West London NHS Trust, UK) on how homophobia results in limitations to accessing effective interventions such as HIV PrEP, mpox vaccination and DoxyPEP.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00302-8/fulltext?dgcid=buzzsprout_icw_podcast_ge...]]></itunes:summary>
    <description><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Manik Kohli (Institute of Global Health at the University College London, UK), Iain Reeves (Homerton Healthcare NHS Trust, UK), and Laura Waters (Central and North West London NHS Trust, UK) on how homophobia results in limitations to accessing effective interventions such as HIV PrEP, mpox vaccination and DoxyPEP.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00302-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00302-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Manik Kohli (Institute of Global Health at the University College London, UK), Iain Reeves (Homerton Healthcare NHS Trust, UK), and Laura Waters (Central and North West London NHS Trust, UK) on how homophobia results in limitations to accessing effective interventions such as HIV PrEP, mpox vaccination and DoxyPEP.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00302-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00302-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/14397839-manik-kohli-iain-reeves-and-laura-waters-on-homophobia-in-the-provision-of-sexual-health-care-in-the-uk.mp3" length="30167901" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14397839</guid>
    <pubDate>Mon, 29 Jan 2024 23:00:00 +0000</pubDate>
    <itunes:duration>2511</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women</itunes:title>
    <title>Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women</title>
    <itunes:summary><![CDATA[Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention adherence and choice of the dapivirine vaginal ring and daily oral PrEP in adolescent girls and young women in Africa.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00227-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue t...]]></itunes:summary>
    <description><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention adherence and choice of the dapivirine vaginal ring and daily oral PrEP in adolescent girls and young women in Africa.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00227-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00227-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention adherence and choice of the dapivirine vaginal ring and daily oral PrEP in adolescent girls and young women in Africa.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00227-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00227-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/14055517-lulu-nair-connie-celum-and-kenneth-ngure-on-dapivirine-vaginal-ring-and-daily-oral-prep-for-hiv-prevention-in-women.mp3" length="10929055" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-14055517</guid>
    <pubDate>Wed, 29 Nov 2023 23:00:00 +0000</pubDate>
    <itunes:duration>908</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Sophia Rein on HIV treatment with INSTIs and cardiovascular events</itunes:title>
    <title>Sophia Rein on HIV treatment with INSTIs and cardiovascular events</title>
    <itunes:summary><![CDATA[Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/13888400-sophia-rein-on-hiv-treatment-with-instis-and-cardiovascular-events.mp3" length="11011082" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-13888400</guid>
    <pubDate>Wed, 01 Nov 2023 23:00:00 +0000</pubDate>
    <itunes:duration>915</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist</itunes:title>
    <title>Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist</title>
    <itunes:summary><![CDATA[Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability of HIV drug resistance studies.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00173-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ htt...]]></itunes:summary>
    <description><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability of HIV drug resistance studies.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00173-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00173-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability of HIV drug resistance studies.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00173-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00173-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/13722349-lawrence-mbuagbaw-on-reporting-of-hiv-drug-resistance-in-clinical-studies-using-the-cedric-hiv-checklist.mp3" length="6793741" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-13722349</guid>
    <pubDate>Thu, 05 Oct 2023 15:00:00 +0100</pubDate>
    <itunes:duration>563</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence</itunes:title>
    <title>Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence</title>
    <itunes:summary><![CDATA[We talk to Andreas Jahn (Malawi Ministry of Health) and Nellie Wadonda-Kabondo (US CDC, Lilongwe, Malawi) about trends in HIV prevalence and incidence derived from two successive PHIA studies, and Malawi's progress towards achieving 95-95-95 goal.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00144-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https:...]]></itunes:summary>
    <description><![CDATA[<p>We talk to Andreas Jahn (Malawi Ministry of Health) and Nellie Wadonda-Kabondo (US CDC, Lilongwe, Malawi) about trends in HIV prevalence and incidence derived from two successive PHIA studies, and Malawi&apos;s progress towards achieving 95-95-95 goal.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00144-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00144-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>We talk to Andreas Jahn (Malawi Ministry of Health) and Nellie Wadonda-Kabondo (US CDC, Lilongwe, Malawi) about trends in HIV prevalence and incidence derived from two successive PHIA studies, and Malawi&apos;s progress towards achieving 95-95-95 goal.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00144-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00144-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/13511201-andreas-jahn-and-nellie-wadonda-kabondo-on-trends-in-hiv-prevalence-and-incidence.mp3" length="17478299" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-13511201</guid>
    <pubDate>Fri, 01 Sep 2023 15:00:00 +0100</pubDate>
    <itunes:duration>1454</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations</itunes:title>
    <title>Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations</title>
    <itunes:summary><![CDATA[Deputy Editor Adrian Gonzalez interviews Eryn Braley (Cree/settler, Saddle Lake Cree Nation, University of British Columbia) and Mckenzie Braley (Cree/settler, Saddle Lake Cree Nation, Simon Fraser University) to discuss about the unique perspective that Indigenous Peoples have on the HIV epidemic, and the interactions between Indigenous identities and HIV.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00106-6/fulltext?dgcid=buzzsprout_icw_podcast_...]]></itunes:summary>
    <description><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Eryn Braley (Cree/settler, Saddle Lake Cree Nation, University of British Columbia) and Mckenzie Braley (Cree/settler, Saddle Lake Cree Nation, Simon Fraser University) to discuss about the unique perspective that Indigenous Peoples have on the HIV epidemic, and the interactions between Indigenous identities and HIV.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00106-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00106-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Deputy Editor Adrian Gonzalez interviews Eryn Braley (Cree/settler, Saddle Lake Cree Nation, University of British Columbia) and Mckenzie Braley (Cree/settler, Saddle Lake Cree Nation, Simon Fraser University) to discuss about the unique perspective that Indigenous Peoples have on the HIV epidemic, and the interactions between Indigenous identities and HIV.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00106-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00106-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/13388928-eryn-braley-and-mckenzie-braley-on-experiences-of-hiv-among-global-indigenous-populations.mp3" length="15391236" type="audio/mpeg" />
    <itunes:author>The Lancet Group</itunes:author>
    <guid isPermaLink="false">Buzzsprout-13388928</guid>
    <pubDate>Fri, 11 Aug 2023 15:00:00 +0100</pubDate>
    <itunes:duration>1280</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español)</itunes:title>
    <title>Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español)</title>
    <itunes:summary><![CDATA[Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria "Red Somos", Colombia) sobre la situación sanitaria de los migrantes Venezolanos con VIH en Colombia.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00085-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversati...]]></itunes:summary>
    <description><![CDATA[<p>Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria &quot;Red Somos&quot;, Colombia) sobre la situación sanitaria de los migrantes Venezolanos con VIH en Colombia.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00085-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00085-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria &quot;Red Somos&quot;, Colombia) sobre la situación sanitaria de los migrantes Venezolanos con VIH en Colombia.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00085-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00085-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/13172144-ricardo-luque-and-miguel-barriga-on-hiv-prevalence-and-care-continuum-among-migrants-from-venezuela-in-colombia-en-espanol.mp3" length="32521463" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-13172144</guid>
    <pubDate>Thu, 06 Jul 2023 16:00:00 +0100</pubDate>
    <itunes:duration>2707</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Denton Callander on the effects of treatment as prevention</itunes:title>
    <title>Denton Callander on the effects of treatment as prevention</title>
    <itunes:summary><![CDATA[Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00050-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/t...]]></itunes:summary>
    <description><![CDATA[<p>Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00050-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00050-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00050-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00050-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/12960304-denton-callander-on-the-effects-of-treatment-as-prevention.mp3" length="13696241" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-12960304</guid>
    <pubDate>Thu, 01 Jun 2023 23:00:00 +0100</pubDate>
    <itunes:duration>1139</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women</itunes:title>
    <title>Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women</title>
    <itunes:summary><![CDATA[Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_lanhiv_lancet Continue this conversation on social! Follow us today at... https://thelancet.bsky.so...]]></itunes:summary>
    <description><![CDATA[<p>Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_lanhiv_lancet'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_lanhiv_lancet</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_lanhiv_lancet'>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00008-5/fulltext?dgcid=buzzsprout_icw_podcast_lanhiv_lancet</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/12775217-andrea-wirtz-and-sari-reisner-on-hiv-incidence-and-mortality-among-transgender-women.mp3" length="18817442" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-12775217</guid>
    <pubDate>Thu, 04 May 2023 23:00:00 +0100</pubDate>
    <itunes:duration>1565</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Yasmin Mohamed on early infant diagnosis of HIV</itunes:title>
    <title>Yasmin Mohamed on early infant diagnosis of HIV</title>
    <itunes:summary><![CDATA[Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea.  Read the full article: The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/...]]></itunes:summary>
    <description><![CDATA[<p>Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00001-2/fulltext'>The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00001-2/fulltext'>The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/12643588-yasmin-mohamed-on-early-infant-diagnosis-of-hiv.mp3" length="12565221" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-12643588</guid>
    <pubDate>Thu, 13 Apr 2023 15:00:00 +0100</pubDate>
    <itunes:duration>1044</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV</itunes:title>
    <title>Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV</title>
    <itunes:summary><![CDATA[Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade.  Read the full article: The effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment ...]]></itunes:summary>
    <description><![CDATA[<p>Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women&apos;s risk of HIV acquisition and engagement in the HIV treatment and care cascade.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00305-8/fulltext'>The effects of intimate partner violence on women&apos;s risk of HIV acquisition and engagement in the HIV treatment and care cascade</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women&apos;s risk of HIV acquisition and engagement in the HIV treatment and care cascade.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00305-8/fulltext'>The effects of intimate partner violence on women&apos;s risk of HIV acquisition and engagement in the HIV treatment and care cascade</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/12162034-salome-kuchukhidze-and-francisco-mbofana-on-intimate-partner-violence-and-women-with-hiv.mp3" length="16429440" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-12162034</guid>
    <pubDate>Wed, 01 Feb 2023 12:00:00 +0000</pubDate>
    <itunes:duration>1366</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa</itunes:title>
    <title>Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa</title>
    <itunes:summary><![CDATA[Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa.   Read the full article: Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPT...]]></itunes:summary>
    <description><![CDATA[<p>Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa. <br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00251-X/fulltext'>Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa. <br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00251-X/fulltext'>Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/11870211-lise-jamieson-and-gesine-mayer-rath-on-cabotegravir-for-prep-in-south-africa.mp3" length="18792349" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-11870211</guid>
    <pubDate>Wed, 14 Dec 2022 11:00:00 +0000</pubDate>
    <itunes:duration>1563</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Helen Ayles and Musonda Simwinge on the PopART trial</itunes:title>
    <title>Helen Ayles and Musonda Simwinge on the PopART trial</title>
    <itunes:summary><![CDATA[Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV.  Read the PopART trial papers: Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community  Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2  Projected outcomes of unive...]]></itunes:summary>
    <description><![CDATA[<p>Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of <em>The Lancet HIV</em>.<br/><br/>Read the PopART trial papers:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00237-5/fulltext'>Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community</a><br/><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00253-3/fulltext'>Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2</a><br/><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00259-4/fulltext'>Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa</a><br/><br/></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of <em>The Lancet HIV</em>.<br/><br/>Read the PopART trial papers:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00237-5/fulltext'>Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community</a><br/><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00253-3/fulltext'>Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2</a><br/><br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00259-4/fulltext'>Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa</a><br/><br/></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/11646827-helen-ayles-and-musonda-simwinge-on-the-popart-trial.mp3" length="21309773" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-11646827</guid>
    <pubDate>Mon, 07 Nov 2022 15:00:00 +0000</pubDate>
    <itunes:duration>1773</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Carol Strong and Stephane Ku on HIV and chemsex</itunes:title>
    <title>Carol Strong and Stephane Ku on HIV and chemsex</title>
    <itunes:summary><![CDATA[Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.  Read the full Review: HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men   Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://li...]]></itunes:summary>
    <description><![CDATA[<p>Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.<br/><br/>Read the full Review:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00124-2/fulltext'>HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men</a><br/><br/></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.<br/><br/>Read the full Review:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00124-2/fulltext'>HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men</a><br/><br/></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/11400300-carol-strong-and-stephane-ku-on-hiv-and-chemsex.mp3" length="12807220" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-11400300</guid>
    <pubDate>Wed, 28 Sep 2022 15:00:00 +0100</pubDate>
    <itunes:duration>1064</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Elijah Kakande and Gabriel Chamie on TB interventions for people with HIV</itunes:title>
    <title>Elijah Kakande and Gabriel Chamie on TB interventions for people with HIV</title>
    <itunes:summary><![CDATA[Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.  Read the full article: A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ htt...]]></itunes:summary>
    <description><![CDATA[<p>Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00166-7/fulltext'>A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00166-7/fulltext'>A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/11208090-elijah-kakande-and-gabriel-chamie-on-tb-interventions-for-people-with-hiv.mp3" length="15402798" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-11208090</guid>
    <pubDate>Tue, 30 Aug 2022 23:00:00 +0100</pubDate>
    <itunes:duration>1281</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Amir Mohareb on PrEP and hepatitis B</itunes:title>
    <title>Amir Mohareb on PrEP and hepatitis B</title>
    <itunes:summary><![CDATA[Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B.   Read the full article: Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B. <br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00123-0/fulltext'>Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B. <br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00123-0/fulltext'>Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/11029583-amir-mohareb-on-prep-and-hepatitis-b.mp3" length="9548683" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-11029583</guid>
    <pubDate>Tue, 26 Jul 2022 23:00:00 +0100</pubDate>
    <itunes:duration>793</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Kenneth Ngure on PrEP in Kenya</itunes:title>
    <title>Kenneth Ngure on PrEP in Kenya</title>
    <itunes:summary><![CDATA[Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.  Read the full article: Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the...]]></itunes:summary>
    <description><![CDATA[<p>Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00126-6/fulltext'>Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.<br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00126-6/fulltext'>Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/10888775-kenneth-ngure-on-prep-in-kenya.mp3" length="9435822" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10888775</guid>
    <pubDate>Fri, 01 Jul 2022 10:00:00 +0100</pubDate>
    <itunes:duration>784</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Marta Vasylyev and Casper Rokx on HIV care for displaced Ukranians</itunes:title>
    <title>Marta Vasylyev and Casper Rokx on HIV care for displaced Ukranians</title>
    <itunes:summary><![CDATA[Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/t...]]></itunes:summary>
    <description><![CDATA[<p>Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/10711548-marta-vasylyev-and-casper-rokx-on-hiv-care-for-displaced-ukranians.mp3" length="16081132" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10711548</guid>
    <pubDate>Tue, 31 May 2022 23:00:00 +0100</pubDate>
    <itunes:duration>1337</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Angela Colbers and Hylke Waalewijn on treatment for children with HIV</itunes:title>
    <title>Angela Colbers and Hylke Waalewijn on treatment for children with HIV</title>
    <itunes:summary><![CDATA[Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV.   Read the full article: Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagra...]]></itunes:summary>
    <description><![CDATA[<p>Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV. <br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00292-7/fulltext'>Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV. <br/><br/>Read the full article:<br/><a href='https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00292-7/fulltext'>Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/10548584-angela-colbers-and-hylke-waalewijn-on-treatment-for-children-with-hiv.mp3" length="15036031" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10548584</guid>
    <pubDate>Tue, 03 May 2022 09:00:00 +0100</pubDate>
    <itunes:duration>1250</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Nabila El-Bassel on intimate partner violence and HIV </itunes:title>
    <title>Nabila El-Bassel on intimate partner violence and HIV </title>
    <itunes:summary><![CDATA[Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/10165767-nabila-el-bassel-on-intimate-partner-violence-and-hiv.mp3" length="11432357" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10165767</guid>
    <pubDate>Tue, 01 Mar 2022 23:00:00 +0000</pubDate>
    <itunes:duration>950</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Amy Justice on ageing with HIV</itunes:title>
    <title>Amy Justice on ageing with HIV</title>
    <itunes:summary><![CDATA[Dr Amy Justice (Yale University, USA) talks to Philippa Harris about the joint The Lancet HIV and The Lancet Healthy Longevity Series Ageing with HIV.  Read the Series: Ageing with HIV Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Dr Amy Justice (Yale University, USA) talks to Philippa Harris about the joint <em>The Lancet HIV</em> and <em>The Lancet Healthy Longevity</em> Series Ageing with HIV.<br/><br/>Read the Series:<br/><a href='https://www.thelancet.com/series/ageing-with-hiv'>Ageing with HIV</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Dr Amy Justice (Yale University, USA) talks to Philippa Harris about the joint <em>The Lancet HIV</em> and <em>The Lancet Healthy Longevity</em> Series Ageing with HIV.<br/><br/>Read the Series:<br/><a href='https://www.thelancet.com/series/ageing-with-hiv'>Ageing with HIV</a></p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/10129216-amy-justice-on-ageing-with-hiv.mp3" length="10895963" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-10129216</guid>
    <pubDate>Wed, 23 Feb 2022 23:00:00 +0000</pubDate>
    <itunes:duration>905</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Bridget Mugisa on the epidemiology of HIV in the Middle East and north Africa</itunes:title>
    <title>Bridget Mugisa on the epidemiology of HIV in the Middle East and north Africa</title>
    <itunes:summary><![CDATA[Peter Hayward talks to Dr Bridget Mugisa (WHO, Eastern Mediterranean Office, Egypt) about a study summarising the epidemiology of HIV in the Middle East and north Africa.  Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Peter Hayward talks to Dr Bridget Mugisa (WHO, Eastern Mediterranean Office, Egypt) about a study summarising the epidemiology of HIV in the Middle East and north Africa. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Peter Hayward talks to Dr Bridget Mugisa (WHO, Eastern Mediterranean Office, Egypt) about a study summarising the epidemiology of HIV in the Middle East and north Africa. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/9991993-bridget-mugisa-on-the-epidemiology-of-hiv-in-the-middle-east-and-north-africa.mp3" length="10746845" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9991993</guid>
    <pubDate>Tue, 01 Feb 2022 23:00:00 +0000</pubDate>
    <itunes:duration>893</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Aaloke Mody and Izukanji Sikazwe on universal HIV treatment in Zambia</itunes:title>
    <title>Aaloke Mody and Izukanji Sikazwe on universal HIV treatment in Zambia</title>
    <itunes:summary><![CDATA[Philippa Harris talks to Dr Aaloke Mody (Washington University School of Medicine, USA) and Izukanji Sikazwe (CIDRZ, Zambia) about their study on universal HIV treatment in Zambia.   Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00186-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/...]]></itunes:summary>
    <description><![CDATA[<p>Philippa Harris talks to Dr Aaloke Mody (Washington University School of Medicine, USA) and Izukanji Sikazwe (CIDRZ, Zambia) about their study on universal HIV treatment in Zambia. <br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00186-7/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Philippa Harris talks to Dr Aaloke Mody (Washington University School of Medicine, USA) and Izukanji Sikazwe (CIDRZ, Zambia) about their study on universal HIV treatment in Zambia. <br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00186-7/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/9628253-aaloke-mody-and-izukanji-sikazwe-on-universal-hiv-treatment-in-zambia.mp3" length="15904341" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9628253</guid>
    <pubDate>Mon, 29 Nov 2021 23:00:00 +0000</pubDate>
    <itunes:duration>1323</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>José Miro and Juliana Reyes on COVID-19 in people living with HIV</itunes:title>
    <title>José Miro and Juliana Reyes on COVID-19 in people living with HIV</title>
    <itunes:summary><![CDATA[Prof José Miro (University of Barcelona) and Dr Juliana Reyes (Public Health Agency of Catalonia) speak to Editor-in-Chief Peter Hayward about SARS-CoV-2 and COVID-19 in people living with HIV.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00240-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/c...]]></itunes:summary>
    <description><![CDATA[<p>Prof José Miro (University of Barcelona) and Dr Juliana Reyes (Public Health Agency of Catalonia) speak to Editor-in-Chief Peter Hayward about SARS-CoV-2 and COVID-19 in people living with HIV.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00240-X/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Prof José Miro (University of Barcelona) and Dr Juliana Reyes (Public Health Agency of Catalonia) speak to Editor-in-Chief Peter Hayward about SARS-CoV-2 and COVID-19 in people living with HIV.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00240-X/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/9470452-jose-miro-and-juliana-reyes-on-covid-19-in-people-living-with-hiv.mp3" length="20020186" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9470452</guid>
    <pubDate>Mon, 01 Nov 2021 23:00:00 +0000</pubDate>
    <itunes:duration>1666</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Jon Shuter on smokers with HIV</itunes:title>
    <title>Jon Shuter on smokers with HIV</title>
    <itunes:summary><![CDATA[Prof Jon Shuter (Albert Einstein College of Medicine, USA) talks to Dr Philippa Harris about harm reduction for smokers with HIV.   Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00156-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Prof Jon Shuter (Albert Einstein College of Medicine, USA) talks to Dr Philippa Harris about harm reduction for smokers with HIV. <br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00156-9/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Prof Jon Shuter (Albert Einstein College of Medicine, USA) talks to Dr Philippa Harris about harm reduction for smokers with HIV. <br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00156-9/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/9226756-jon-shuter-on-smokers-with-hiv.mp3" length="18024884" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9226756</guid>
    <pubDate>Mon, 27 Sep 2021 23:00:00 +0100</pubDate>
    <itunes:duration>1499</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Elizabeth Marie King on menopausal hormone therapy</itunes:title>
    <title>Elizabeth Marie King on menopausal hormone therapy</title>
    <itunes:summary><![CDATA[Peter Hayward talks to Dr Elizabeth Marie King (University of British Columbia, Canada) about a Viewpoint on menopausal hormone therapy for women living with HIV.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00148-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtu...]]></itunes:summary>
    <description><![CDATA[<p>Peter Hayward talks to Dr Elizabeth Marie King (University of British Columbia, Canada) about a Viewpoint on menopausal hormone therapy for women living with HIV.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00148-X/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Peter Hayward talks to Dr Elizabeth Marie King (University of British Columbia, Canada) about a Viewpoint on menopausal hormone therapy for women living with HIV.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00148-X/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/9114924-elizabeth-marie-king-on-menopausal-hormone-therapy.mp3" length="10562785" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-9114924</guid>
    <pubDate>Tue, 31 Aug 2021 23:00:00 +0100</pubDate>
    <itunes:duration>877</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>John Frater on COVID-19 vaccination and HIV</itunes:title>
    <title>John Frater on COVID-19 vaccination and HIV</title>
    <itunes:summary><![CDATA[John Frater (University of Oxford) talks to Deputy Editor Philippa Harris about COVID-19 and SARS-CoV-2 vaccination in people with HIV.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00103-X/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>John Frater (University of Oxford) talks to Deputy Editor Philippa Harris about COVID-19 and SARS-CoV-2 vaccination in people with HIV.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00103-X/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>John Frater (University of Oxford) talks to Deputy Editor Philippa Harris about COVID-19 and SARS-CoV-2 vaccination in people with HIV.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00103-X/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/8910961-john-frater-on-covid-19-vaccination-and-hiv.mp3" length="14384590" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8910961</guid>
    <pubDate>Tue, 03 Aug 2021 11:00:00 +0100</pubDate>
    <itunes:duration>1196</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Elias Dah on PrEP in west Africa</itunes:title>
    <title>Elias Dah on PrEP in west Africa</title>
    <itunes:summary><![CDATA[Dr Elias Dah (Institut National de Santé Publique, Centre Muraz, Bobo Dioulasso, Burkina Faso) joins Peter Hayward to discuss a PrEP implementation project in four countries in west Africa.   Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00005-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com...]]></itunes:summary>
    <description><![CDATA[<p>Dr Elias Dah (Institut National de Santé Publique, Centre Muraz, Bobo Dioulasso, Burkina Faso) joins Peter Hayward to discuss a PrEP implementation project in four countries in west Africa. <br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00005-9/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Dr Elias Dah (Institut National de Santé Publique, Centre Muraz, Bobo Dioulasso, Burkina Faso) joins Peter Hayward to discuss a PrEP implementation project in four countries in west Africa. <br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00005-9/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/8775583-elias-dah-on-prep-in-west-africa.mp3" length="11984646" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8775583</guid>
    <pubDate>Mon, 28 Jun 2021 23:00:00 +0100</pubDate>
    <itunes:duration>996</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Fatima Mir on the 2019 HIV outbreak in Pakistan</itunes:title>
    <title>Fatima Mir on the 2019 HIV outbreak in Pakistan</title>
    <itunes:summary><![CDATA[Fatima Mir (Aga Khan University, Pakistan) talks to Philippa Harris about the 2019 HIV outbreak in the Larkana District of Pakistan.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00049-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Fatima Mir (Aga Khan University, Pakistan) talks to Philippa Harris about the 2019 HIV outbreak in the Larkana District of Pakistan.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00049-7/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Fatima Mir (Aga Khan University, Pakistan) talks to Philippa Harris about the 2019 HIV outbreak in the Larkana District of Pakistan.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00049-7/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/8604343-fatima-mir-on-the-2019-hiv-outbreak-in-pakistan.mp3" length="13318802" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8604343</guid>
    <pubDate>Tue, 01 Jun 2021 23:00:00 +0100</pubDate>
    <itunes:duration>1107</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Jessica Castilho and Claudia Cortes on HIV life expectancy in Latin America and the Caribbean</itunes:title>
    <title>Jessica Castilho and Claudia Cortes on HIV life expectancy in Latin America and the Caribbean</title>
    <itunes:summary><![CDATA[Dr Jessica Castilho (Vanderbilt University Medical Centre) and Dr Claudia Cortes (University of Chile School of Medicine) join Peter Hayward to discuss their research on life expectancy for people living with HIV in Latin America and the Caribbean.   Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30358-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https:...]]></itunes:summary>
    <description><![CDATA[<p>Dr Jessica Castilho (Vanderbilt University Medical Centre) and Dr Claudia Cortes (University of Chile School of Medicine) join Peter Hayward to discuss their research on life expectancy for people living with HIV in Latin America and the Caribbean. <br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30358-1/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Dr Jessica Castilho (Vanderbilt University Medical Centre) and Dr Claudia Cortes (University of Chile School of Medicine) join Peter Hayward to discuss their research on life expectancy for people living with HIV in Latin America and the Caribbean. <br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30358-1/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/8405346-jessica-castilho-and-claudia-cortes-on-hiv-life-expectancy-in-latin-america-and-the-caribbean.mp3" length="9569173" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8405346</guid>
    <pubDate>Mon, 26 Apr 2021 23:00:00 +0100</pubDate>
    <itunes:duration>795</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Chloe Orkin on long-acting cabotegravir</itunes:title>
    <title>Chloe Orkin on long-acting cabotegravir</title>
    <itunes:summary><![CDATA[Professor Chloe Orkin (Queen Mary University London, UK) joins Peter Hayward to talk about long-acting cabotegravir for HIV treatment and the 96 weeks of the FLAIR study.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30340-4/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https...]]></itunes:summary>
    <description><![CDATA[<p>Professor Chloe Orkin (Queen Mary University London, UK) joins Peter Hayward to talk about long-acting cabotegravir for HIV treatment and the 96 weeks of the FLAIR study.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30340-4/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Professor Chloe Orkin (Queen Mary University London, UK) joins Peter Hayward to talk about long-acting cabotegravir for HIV treatment and the 96 weeks of the FLAIR study.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30340-4/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/8232223-chloe-orkin-on-long-acting-cabotegravir.mp3" length="11589375" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8232223</guid>
    <pubDate>Mon, 29 Mar 2021 23:00:00 +0100</pubDate>
    <itunes:duration>963</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Sarah Calabrese on U=U</itunes:title>
    <title>Sarah Calabrese on U=U</title>
    <itunes:summary><![CDATA[Sarah Calabrese (George Washington University, USA) talks to Deputy Editor Philippa Harris about prioritising sexual pleasure and correcting misinformation in the era of U=U.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet h...]]></itunes:summary>
    <description><![CDATA[<p>Sarah Calabrese (George Washington University, USA) talks to Deputy Editor Philippa Harris about prioritising sexual pleasure and correcting misinformation in the era of U=U.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Sarah Calabrese (George Washington University, USA) talks to Deputy Editor Philippa Harris about prioritising sexual pleasure and correcting misinformation in the era of U=U.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/8051868-sarah-calabrese-on-u-u.mp3" length="12515643" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-8051868</guid>
    <pubDate>Mon, 01 Mar 2021 23:00:00 +0000</pubDate>
    <itunes:duration>1040</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Le Minh Giang and Todd Korthuis on opioid use disorder and HIV in Vietnam</itunes:title>
    <title>Le Minh Giang and Todd Korthuis on opioid use disorder and HIV in Vietnam</title>
    <itunes:summary><![CDATA[Le Minh Giang (Hanoi Medical University, Vietnam) and Todd Korthuis (Oregon Health and Science University, USA) discuss their work in Vietnam on treating opioid use disorder in people with HIV with Deputy Editor Philippa Harris.  Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30302-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetme...]]></itunes:summary>
    <description><![CDATA[<p>Le Minh Giang (Hanoi Medical University, Vietnam) and Todd Korthuis (Oregon Health and Science University, USA) discuss their work in Vietnam on treating opioid use disorder in people with HIV with Deputy Editor Philippa Harris.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30302-7/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Le Minh Giang (Hanoi Medical University, Vietnam) and Todd Korthuis (Oregon Health and Science University, USA) discuss their work in Vietnam on treating opioid use disorder in people with HIV with Deputy Editor Philippa Harris.<br/><br/>Read the full article:<br/>https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30302-7/fulltext</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/7605115-le-minh-giang-and-todd-korthuis-on-opioid-use-disorder-and-hiv-in-vietnam.mp3" length="10875046" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-7605115</guid>
    <pubDate>Mon, 01 Feb 2021 23:00:00 +0000</pubDate>
    <itunes:duration>903</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-Bather</itunes:title>
    <title>Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-Bather</title>
    <itunes:summary><![CDATA[In a bumper edition, we talk to contributors to several papers in the December issue on diverse topics that include test-and-treat in correctional facilities, PrEP engagement in transgender women, the burden of living with HIV in MSM, and gentrification in San Francisco.  Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https:...]]></itunes:summary>
    <description><![CDATA[<p>In a bumper edition, we talk to contributors to several papers in the December issue on diverse topics that include test-and-treat in correctional facilities, PrEP engagement in transgender women, the burden of living with HIV in MSM, and gentrification in San Francisco. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>In a bumper edition, we talk to contributors to several papers in the December issue on diverse topics that include test-and-treat in correctional facilities, PrEP engagement in transgender women, the burden of living with HIV in MSM, and gentrification in San Francisco. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/6749173-michael-herce-tonia-poteat-ward-van-bilsen-and-hanne-zimmerman-and-jade-pagkas-bather.mp3" length="38596742" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-6749173</guid>
    <pubDate>Tue, 08 Dec 2020 11:00:00 +0000</pubDate>
    <itunes:duration>3214</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Mathebe Kopo and Alain Amstutz on HIV testing and the HOSENG trial</itunes:title>
    <title>Mathebe Kopo and Alain Amstutz on HIV testing and the HOSENG trial</title>
    <itunes:summary><![CDATA[Deputy Editor Philippa Harris discusses HIV testing and the HOSENG trial with researchers Mathebe Kopo (SolidarMed, Lesotho) and Alain Amstutz (Swiss Tropical and Public Health Institute, Basel, Switzerland). Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Deputy Editor Philippa Harris discusses HIV testing and the HOSENG trial with researchers Mathebe Kopo (SolidarMed, Lesotho) and Alain Amstutz (Swiss Tropical and Public Health Institute, Basel, Switzerland).</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Deputy Editor Philippa Harris discusses HIV testing and the HOSENG trial with researchers Mathebe Kopo (SolidarMed, Lesotho) and Alain Amstutz (Swiss Tropical and Public Health Institute, Basel, Switzerland).</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/6107374-mathebe-kopo-and-alain-amstutz-on-hiv-testing-and-the-hoseng-trial.mp3" length="20170340" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-6107374</guid>
    <pubDate>Wed, 28 Oct 2020 23:00:00 +0000</pubDate>
    <itunes:duration>1678</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Susannah Mayhew on integrating sexual health and HIV services</itunes:title>
    <title>Susannah Mayhew on integrating sexual health and HIV services</title>
    <itunes:summary><![CDATA[Susannah Mayhew (London School of Hygiene and Tropical Medicine) joins Deputy Editor Philippa Harris to discuss integration of sexual and reproductive health and HIV services.  Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Susannah Mayhew (London School of Hygiene and Tropical Medicine) joins Deputy Editor Philippa Harris to discuss integration of sexual and reproductive health and HIV services. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Susannah Mayhew (London School of Hygiene and Tropical Medicine) joins Deputy Editor Philippa Harris to discuss integration of sexual and reproductive health and HIV services. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/5676232-susannah-mayhew-on-integrating-sexual-health-and-hiv-services.mp3" length="9914239" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-5676232</guid>
    <pubDate>Wed, 30 Sep 2020 15:00:00 +0100</pubDate>
    <itunes:duration>823</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Ankur Gupta-Wright and Melanie Alufandika-Moyo on HIV drug resistance in Malawi</itunes:title>
    <title>Ankur Gupta-Wright and Melanie Alufandika-Moyo on HIV drug resistance in Malawi</title>
    <itunes:summary><![CDATA[Editor-in-Chief, Peter Hayward, talks to researchers from London School of Hygiene and Tropical Medicine and Melanie Alufandika-Moyo Malawi-Liverpool Wellcome Trust about their research on virological failure and HIV drug resistance in patients with HIV in hospital in Malawi. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https:/...]]></itunes:summary>
    <description><![CDATA[<p>Editor-in-Chief, Peter Hayward, talks to researchers from London School of Hygiene and Tropical Medicine and Melanie Alufandika-Moyo Malawi-Liverpool Wellcome Trust about their research on virological failure and HIV drug resistance in patients with HIV in hospital in Malawi.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Editor-in-Chief, Peter Hayward, talks to researchers from London School of Hygiene and Tropical Medicine and Melanie Alufandika-Moyo Malawi-Liverpool Wellcome Trust about their research on virological failure and HIV drug resistance in patients with HIV in hospital in Malawi.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/5293269-ankur-gupta-wright-and-melanie-alufandika-moyo-on-hiv-drug-resistance-in-malawi.mp3" length="11011104" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-5293269</guid>
    <pubDate>Fri, 04 Sep 2020 10:00:00 +0100</pubDate>
    <itunes:duration>915</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Di Gibb and Anna Turkova on dolutegravir for children with HIV</itunes:title>
    <title>Di Gibb and Anna Turkova on dolutegravir for children with HIV</title>
    <itunes:summary><![CDATA[Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thel...]]></itunes:summary>
    <description><![CDATA[<p>Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/4844660-di-gibb-and-anna-turkova-on-dolutegravir-for-children-with-hiv.mp3" length="16172970" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-4844660</guid>
    <pubDate>Tue, 04 Aug 2020 23:00:00 +0100</pubDate>
    <itunes:duration>1345</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Chi-Chi Udeagu on the impact of COVID-19 on HIV in NYC</itunes:title>
    <title>Chi-Chi Udeagu on the impact of COVID-19 on HIV in NYC</title>
    <itunes:summary><![CDATA[Deputy Editor Philippa Harris talks to Chi-Chi Udeagu (New York City Department of Health and Mental Hygiene, USA) about HIV partner services in New York City and the impact of COVID-19.  Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Deputy Editor Philippa Harris talks to Chi-Chi Udeagu (New York City Department of Health and Mental Hygiene, USA) about HIV partner services in New York City and the impact of COVID-19. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Deputy Editor Philippa Harris talks to Chi-Chi Udeagu (New York City Department of Health and Mental Hygiene, USA) about HIV partner services in New York City and the impact of COVID-19. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/4399736-chi-chi-udeagu-on-the-impact-of-covid-19-on-hiv-in-nyc.mp3" length="18054084" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-4399736</guid>
    <pubDate>Wed, 01 Jul 2020 15:00:00 +0100</pubDate>
    <itunes:duration>1502</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Kelly Dooley and Gavin Churchyard on TB prevention in people with HIV</itunes:title>
    <title>Kelly Dooley and Gavin Churchyard on TB prevention in people with HIV</title>
    <itunes:summary><![CDATA[Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris.  Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris. </p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/4025063-kelly-dooley-and-gavin-churchyard-on-tb-prevention-in-people-with-hiv.mp3" length="11186000" type="audio/mpeg" />
    <itunes:author>The Lancet HIV</itunes:author>
    <guid isPermaLink="false">Buzzsprout-4025063</guid>
    <pubDate>Wed, 03 Jun 2020 23:00:00 +0100</pubDate>
    <itunes:duration>929</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The London Patient on being cured of HIV</itunes:title>
    <title>The London Patient on being cured of HIV</title>
    <itunes:summary><![CDATA[Adam Castillejo joins The Lancet HIV’s Editor, Peter Hayward, to talk about his experience of HIV, cancer, and becoming the second person to be cured of HIV. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv ]]></itunes:summary>
    <description><![CDATA[<p>Adam Castillejo joins <em>The Lancet HIV</em>’s Editor, Peter Hayward, to talk about his experience of HIV, cancer, and becoming the second person to be cured of HIV.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></description>
    <content:encoded><![CDATA[<p>Adam Castillejo joins <em>The Lancet HIV</em>’s Editor, Peter Hayward, to talk about his experience of HIV, cancer, and becoming the second person to be cured of HIV.</p><p>Continue this conversation on social!<br/>Follow us today at...<br/><a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br/><a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br/><a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br/><a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br/><a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/1062154/episodes/3612751-the-london-patient-on-being-cured-of-hiv.mp3" length="26839333" type="audio/mpeg" />
    <itunes:author>Lancet</itunes:author>
    <guid isPermaLink="false">Buzzsprout-3612751</guid>
    <pubDate>Mon, 04 May 2020 13:00:00 +0100</pubDate>
    <itunes:duration>2234</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
</channel>
</rss>
